Publications: Priv.-Doz. Dr. med. J. Rech

Alten R, Burkhardt H, Feist E, Krüger K, Rech J, Rubbert-Roth A, Voll RE, Elbez Y, Rauch C: Abatacept used in combination with non-methotrexate disease-modifying antirheumatic drugs: a descriptive analysis of data from interventional trials and the real-world setting. Arthritis Res Ther. 2018;20(1): 1
Soare A, Weber S, Maul L, Rauber S, Gheorghiu AM, Luber M, Houssni I, Kleyer A, von Pickardt G, Gado M, Simon D, Rech J, Schett G, Distler JHW, Ramming A: Cutting Edge: Homeostasis of Innate Lymphoid Cells Is Imbalanced in Psoriatic Arthritis. J Immunol. 2018;
Sighart R, Rech J, Hueber A, Blank N, Löhr S, Reis A, Sticht H, Hüffmeier U: Evidence for genetic overlap between adult onset Still's disease and hereditary periodic fever syndromes. Rheumatol Int. 2018;38(1): 111-120
Figueiredo CP, Kleyer A, Simon D, Stemmler F, d'Oliveira I, Weissenfels A, Museyko O, Friedberger A, Hueber AJ, Haschka J, Englbrecht M, Pereira RMR, Rech J, Schett G, Engelke K: Methods for segmentation of rheumatoid arthritis bone erosions in high-resolution peripheral quantitative computed tomography (HR-pQCT). Semin Arthritis Rheum. 2018;47(5): 611-618
Figueiredo CP, Bang H, Cobra JF, Englbrecht M, Hueber AJ, Haschka J, Manger B, Kleyer A, Reiser M, Finzel S, Tony HP, Kleinert S, Wendler J, Schuch F, Ronneberger M, Feuchtenberger M, Fleck M, Manger K, Ochs W, Schmitt-Haendle M, Lorenz HM, Nuesslein H, Alten R, Henes J, Krueger K, Rech J, Schett G: Antimodified protein antibody response pattern influences the risk for disease relapse in patients with rheumatoid arthritis tapering disease modifying antirheumatic drugs. Ann Rheum Dis. 2017;76(2): 399-407
Kavanaugh A, Mease PJ, Reimold AM, Tahir H, Rech J, Hall S, Geusens P, Wang Z, Pricop L, Mpofu S, FUTURE-1 Study Group: Secukinumab for Long-Term Treatment of Psoriatic Arthritis: A Two-Year Followup From a Phase III, Randomized, Double-Blind Placebo-Controlled Study. Arthritis Care Res (Hoboken). 2017;69(3): 347-355
Kleyer A, Beyer L, Simon C, Stemmler F, Englbrecht M, Beyer C, Rech J, Manger B, Krönke G, Schett G, Hueber AJ: Development of three-dimensional prints of arthritic joints for supporting patients' awareness to structural damage. Arthritis Res Ther. 2017;19(1): 34
Werner D, Simon D, Englbrecht M, Stemmler F, Simon C, Berlin A, Haschka J, Renner N, Buder T, Engelke K, Hueber AJ, Rech J, Schett G, Kleyer A: Early Changes of the Cortical Micro-Channel System in the Bare Area of the Joints of Patients With Rheumatoid Arthritis. Arthritis Rheumatol. 2017;69(8): 1580-1587
Grossmayer GE, Keppeler H, Boeltz S, Janko C, Rech J, Herrmann M, Lauber K, Muñoz LE: Elevated Serum Lysophosphatidylcholine in Patients with Systemic Lupus Erythematosus Impairs Phagocytosis of Necrotic Cells In Vitro. Front Immunol. 2017;8: 1876
Simon D, Kleyer A, Stemmler F, Simon C, Berlin A, Hueber AJ, Haschka J, Renner N, Figueiredo C, Neuhuber W, Buder T, Englbrecht M, Rech J, Engelke K, Schett G: Age- and Sex-Dependent Changes of Intra-articular Cortical and Trabecular Bone Structure and the Effects of Rheumatoid Arthritis. J Bone Miner Res. 2017;32(4): 722-730
Stone JH, Tuckwell K, Dimonaco S, Klearman M, Aringer M, Blockmans D, Brouwer E, Cid MC, Dasgupta B, Rech J, Salvarani C, Schett G, Schulze-Koops H, Spiera R, Unizony SH, Collinson N: Trial of Tocilizumab in Giant-Cell Arteritis. N Engl J Med. 2017;377(4): 317-328
Figueiredo C, Simon D, Englbrecht M, Haschka J, Kleyer A, Bayat S, Hueber A, Pereira RM, Rech J, Schett G: QUANTIFICATION AND IMPACT OF SECONDARY OSTEOARTHRITIS USING HR-PQCT IN ANTI-CITRULLINATED PROTEIN ANTIBODY RHEUMATOID ARTHRITIS PATIENTS Osteoporos Int. 2017;28 1: S110-S111
Petsch C, Araujo E, Hueber A, Schett G, Manger B, Rech J: Gout mimicking rheumatoid arthritis. Semin Arthritis Rheum. 2017;46(4): e15
Tuckwell K, Collinson N, Dimonaco S, Klearman M, Blockmans D, Brouwer E, Cid MC, Dasgupta B, Rech J, Salvarani C, Unizony SH, Stone JH, GiACTA Investigators: Newly diagnosed vs. relapsing giant cell arteritis: Baseline data from the GiACTA trial. Semin Arthritis Rheum. 2017;46(5): 657-664
Wunderlich C, Oliviera I, Figueiredo CP, Rech J, Schett G: Effects of DMARDs on citrullinated peptide autoantibody levels in RA patients-A longitudinal analysis. Semin Arthritis Rheum. 2017;46(6): 709-714
Haschka J, Englbrecht M, Hueber AJ, Manger B, Kleyer A, Reiser M, Finzel S, Tony HP, Kleinert S, Feuchtenberger M, Fleck M, Manger K, Ochs W, Schmitt-Haendle M, Wendler J, Schuch F, Ronneberger M, Lorenz HM, Nuesslein H, Alten R, Demary W, Henes J, Schett G, Rech J: Relapse rates in patients with rheumatoid arthritis in stable remission tapering or stopping antirheumatic therapy: interim results from the prospective randomised controlled RETRO study. Ann Rheum Dis. 2016;75(1): 45-51
Faustini F, Simon D, Oliveira I, Kleyer A, Haschka J, Englbrecht M, Cavalcante AR, Kraus S, Tabosa TP, Figueiredo C, Hueber AJ, Kocijan R, Cavallaro A, Schett G, Sticherling M, Rech J: Subclinical joint inflammation in patients with psoriasis without concomitant psoriatic arthritis: a cross-sectional and longitudinal analysis. Ann Rheum Dis. 2016;75(12): 2068-2074
Simon D, Faustini F, Kleyer A, Haschka J, Englbrecht M, Kraus S, Hueber AJ, Kocijan R, Sticherling M, Schett G, Rech J: Analysis of periarticular bone changes in patients with cutaneous psoriasis without associated psoriatic arthritis. Ann Rheum Dis. 2016;75(4): 660-6
Rech J, Hueber AJ, Finzel S, Englbrecht M, Haschka J, Manger B, Kleyer A, Reiser M, Cobra JF, Figueiredo C, Tony HP, Kleinert S, Wendler J, Schuch F, Ronneberger M, Feuchtenberger M, Fleck M, Manger K, Ochs W, Schmitt-Haendle M, Lorenz HM, Nuesslein H, Alten R, Henes J, Krueger K, Schett G: Prediction of disease relapses by multibiomarker disease activity and autoantibody status in patients with rheumatoid arthritis on tapering DMARD treatment. Ann Rheum Dis. 2016;75(9): 1637-44
Figueiredo C, Simon D, Stemmler F, Weissenfels A, Weishaeupl D, Museyko O, Friedberger A, Rech J, Hueber AJ, Haschka J, Schett G, Engelke K, Kleyer A: A COMPARISON OF TWO METHODS TO SEGMENT BONE EROSIONS IN THE METACARPOPHALANGEAL JOINTS OF RHEUMATOID ARTHRITIS PATIENTS Ann Rheum Dis. 2016;75 2: 1222-1222
Simon D, Nas K, Faustini F, Kleyer A, Haschka J, Englbrecht M, Hueber AJ, Kocijan R, Sticherling M, Schett G, Rech J: S100A8 BUT NOT S100A9 LEVEL IS RELATED TO THE EXTENT OF EROSIVE BONE DAMAGE IN PSORIATIC ARTHRITIS PATIENTS Ann Rheum Dis. 2016;75 2: 1225-1225
Liphardt AM, Bruggemann GP, Zaucke F, Eckstein F, Bloch W, Mundermann A, Mester J, Schett G, Rech J, Niehoff A: IMPACT OF IMMOBILIZATION ON SERUM LEVELS OF CARTILAGE OLIGOMERIC MATRIX PROTEIN AND IMPLICATIONS FOR CLINICAL PRACTICE IN MUSCULOSKELETAL DISORDERS Ann Rheum Dis. 2016;75 2: 184-185
Ellmann H, Bayat S, dOliveira I, Englbrecht M, Araujo E, Mendonca S, Cavallaro A, Lell M, Manger B, Schett G, Rech J: A LONGITUDINAL DUAL ENERGY COMPUTED TOMOGRAPHY STUDY ON THE EFFECT OF URATE LOWERING THERAPIES ON THE REDUCTION OF TOPHUS BURDEN IN PATIENTS WITH CHRONIC GOUT Ann Rheum Dis. 2016;75 2: 376-377
Schett G, Wunderlich C, Figueiredo C, Cobra JF, Hueber AJ, Kleyer A, Rech J: EFFECTS OF DMARDS ON CITRULLINATED PEPTIDE AUTOANTIBODY LEVELS IN RA PATIENTS- A LONGITUDINAL ANALYSIS Ann Rheum Dis. 2016;75 2: 453-454
Doliveira I, Mensing W, Figueiredo C, Englbrecht M, Haschka J, Hueber A, Kleyer A, Cavallaro A, Schett G, Rech J: SUBCLINICAL MRI INFLAMMATION DOES NOT PREDICT RELAPSE RISK IN RHEUMATOID ARTHRITIS PATIENTS TAPERING DMARDS Ann Rheum Dis. 2016;75 2: 456-457
Figueiredo CP, Simon D, Englbrecht M, Haschka J, Kleyer A, Bayat S, Hueber AJ, Pereira RM, Rech J, Schett G: QUANTIFICATION AND IMPACT OF SECONDARY OSTEOARTHRITIS IN PATIENTS WITH ANTI-CITRULLINATED PROTEIN ANTIBODIES POSITIVE RHEUMATOID ARTHRITIS Ann Rheum Dis. 2016;75 2: 625-625
Hagen M, Figueiredo C, Cobra JF, Reiser M, Haschka J, Englbrecht M, Hueber A, Manger B, Kleyer A, Finzel S, Tony HP, Wendler J, Kleinert S, Schuch F, Ronneberger M, Feuchtenberger M, Fleck M, Manger K, Ochs W, Schmitt-Haendle M, Lorenz HM, Nuesslein H, Alten R, Henes JC, Krueger K, Schett G, Rech J: EFFECTS OF DMARD TAPERING ON TREATMENT COSTS IN RHEUMATOID ARTHRITIS PATIENTS-AN ANALYSIS FROM THE PROSPECTIVE RANDOMIZED CONTROLLED RETROSTUDY Ann Rheum Dis. 2016;75 2: 688-688
Simon D, Kleyer A, Stemmler F, Simon C, Hueber AJ, Kampylafka E, Englbrecht M, Figueiredo C, Engelke K, Berlin A, Haschka J, Rech J, Schett G: ACCURATE DETERMINATION OF PERIARTICULAR BONE COMPOSITION IN HEALTHY INDIVIDUALS AND COMPARISON TO ACPA-POSITIVE RHEUMATOID ARTHRITIS PATIENTS Ann Rheum Dis. 2016;75 2: 865-866
Figueiredo C, Bang H, Cobra JF, Englbrecht M, Hueber AJ, Haschka J, Manger B, Kleyer A, Reiser M, Finzel S, Tony HP, Kleinert S, Wendler J, Schuch F, Ronneberger M, Feuchtenberger M, Fleck M, Manger K, Ochs W, Schmitt-Haendle M, Lorenz HM, Nuesslein H, Alten R, Henes JC, Krueger K, Rech J, Schett G: ANTI-MODIFIED PROTEIN ANTIBODY RESPONSE PATTERN INFLUENCES THE RISK FOR DISEASE RELAPSE IN RHEUMATOID ARTHRITIS PATIENTS TAPERING DISEASE MODIFYING ANTI-RHEUMATIC DRUGS Ann Rheum Dis. 2016;75 2: 961-962
Bayat S, Aati O, Rech J, Sapsford M, Cavallaro A, Lell M, Araujo E, Petsch C, Stamp LK, Schett G, Manger B, Dalbeth N: Development of a Dual-Energy Computed Tomography Scoring System for Measurement of Urate Deposition in Gout. Arthritis Care Res (Hoboken). 2016;68(6): 769-75
Figueiredo CP, Simon D, Englbrecht M, Haschka J, Kleyer A, Werner D, Bayat S, Hueber A, Pereira RM, Rech J, Schett G: Quantification and impact of secondary osteoarthritis in patients with anti-citrullinated protein antibodies positive rheumatoid arthritis. Arthritis Rheumatol. 2016;68(9): 2114-21
Magorivska I, Muñoz LE, Janko C, Dumych T, Rech J, Schett G, Nimmerjahn F, Bilyy R, Herrmann M: Sialylation of anti-histone immunoglobulin G autoantibodies determines their capabilities to participate in the clearance of late apoptotic cells. Clin Exp Immunol. 2016;184(1): 110-7
Riechers E, Baerlecken NT, Baraliakos X, Bakhsh KAM, Aries PM, Bannert B, Becker K, Brandt-Jurgens JF, Braun J, Ehrenstein B, Euler H, Fleck M, Hein R, Karberg K, Kohler L, Matthias T, Max R, Melzer A, Meyer-Olson D, Rech J, Rockwitz K, Rudwaleit M, Schweikhard E, Sieper J, Stille C, von Hinuber U, Wagener P, Weidemann H, Zinke S, Witte T: INTERSPA: SENSITIVITY AND SPECIFITY OF AUTOANTIBODIES AGAINST CD74 IN EARLY AXIAL SPONDYLOARTHRITIS Clin Exp Rheumatol. 2016;34(4): 739-739
Haschka J, Hirschmann S, Kleyer A, Englbrecht M, Faustini F, Simon D, Figueiredo CP, Schuster L, Muschitz C, Kocijan R, Resch H, Atreya R, Rech J, Neurath MF, Schett G: High-resolution Quantitative Computed Tomography Demonstrates Structural Defects in Cortical and Trabecular Bone in IBD Patients. J Crohns Colitis. 2016;10(5): 532-40
Aschermann S, Englbrecht M, Bergua A, Spriewald BM, Said-Nahal R, Breban M, Schett G, Rech J: Presence of HLA-B27 is associated with changes of serum levels of mediators of the Wnt and hedgehog pathway. Joint Bone Spine. 2016;83(1): 43-6
Girard C, Rech J, Brown M, Allali D, Roux-Lombard P, Spertini F, Schiffrin EJ, Schett G, Manger B, Bas S, Del Val G, Gabay C: Elevated serum levels of free interleukin-18 in adult-onset Still's disease. Rheumatology (Oxford). 2016;55(12): 2237-2247
Petsch C, Araujo EG, Englbrecht M, Bayat S, Cavallaro A, Hueber AJ, Lell M, Schett G, Manger B, Rech J: Prevalence of monosodium urate deposits in a population of rheumatoid arthritis patients with hyperuricemia. Semin Arthritis Rheum. 2016;45(6): 663-8
Kleyer A, Krieter M, Oliveira I, Faustini F, Simon D, Kaemmerer N, Cavalcante A, Tabosa T, Rech J, Hueber A, Schett G: High prevalence of tenosynovial inflammation before onset of rheumatoid arthritis and its link to progression to RA-A combined MRI/CT study. Semin Arthritis Rheum. 2016;46(2): 143-50
Henkemeier U, Alten R, Bannert B, Baraliakos X, Behrens F, Heldmann F, Kiltz U, Köhm M, König R, Leipe J, Müller-Ladner U, Rech J, Riechers E, Rubbert-Roth A, Schmidt RE, Schulze-Koops H, Specker C, Tausche AK, Wassenberg S, Witt M, Witte T, Zernicke J, Burkhardt H: [Do we still need clinical studies in rheumatology?]. Z Rheumatol. 2016;75(1): 4-10
Hecht C, Englbrecht M, Rech J, Schmidt S, Araujo E, Engelke K, Finzel S, Schett G: Additive effect of anti-citrullinated protein antibodies and rheumatoid factor on bone erosions in patients with RA. Ann Rheum Dis. 2015;74(12): 2151-6
Araujo EG, Finzel S, Englbrecht M, Schreiber DA, Faustini F, Hueber A, Nas K, Rech J, Schett G: High incidence of disease recurrence after discontinuation of disease-modifying antirheumatic drug treatment in patients with psoriatic arthritis in remission. Ann Rheum Dis. 2015;74(4): 655-60
Behrens F, Tak PP, Østergaard M, Stoilov R, Wiland P, Huizinga TW, Berenfus VY, Vladeva S, Rech J, Rubbert-Roth A, Korkosz M, Rekalov D, Zupanets IA, Ejbjerg BJ, Geiseler J, Fresenius J, Korolkiewicz RP, Schottelius AJ, Burkhardt H: MOR103, a human monoclonal antibody to granulocyte-macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial. Ann Rheum Dis. 2015;74(6): 1058-64
Alexander T, Sarfert R, Klotsche J, Kühl AA, Rubbert-Roth A, Lorenz HM, Rech J, Hoyer BF, Cheng Q, Waka A, Taddeo A, Wiesener M, Schett G, Burmester GR, Radbruch A, Hiepe F, Voll RE: The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus. Ann Rheum Dis. 2015;74(7): 1474-8
Sergeeva M, Rech J, Schett G, Hess A: Response to peripheral immune stimulation within the brain: magnetic resonance imaging perspective of treatment success. Arthritis Res Ther. 2015;17: 268
Bayat S, Aati O, Rech J, Cavallaro A, Lell M, Araujo E, Petsch C, Stamp LK, Schett GA, Manger B, Dalbeth N: Development of a Dual Energy Computed Tomography Scoring System for Measurement of Urate Deposition in Gout Arthritis Rheumatol. 2015;67 10: -
Kocijan R, Nia A, Muschitz C, Simon D, Geiger C, Haschka J, Kleyer A, Bayat S, Rech J, Kocijan A, Dzirlo L, Graninger M, Resch H: Bone Microstructure Assessed By Hrpqct in Subjects with Hyperuricemia without Arthritis Arthritis Rheumatol. 2015;67 10: -
Rech J, Hueber AJ, Englbrecht M, Finzel S, Haschka J, Manger B, Kleyer A, Reiser M, Tony HP, Kleinert S, Feuchtenberger M, Fleck M, Manger K, Ochs W, Schmitt-Haendle M, Wendler J, Schuch F, Ronneberger M, Lorenz HM, Nusslein H, Alten R, Cobra JF, Henes JC, Kruger K, Schett GA: Prediction of Disease Relapses By Multi-Biomarker Disease Test Activity in Rheumatoid Arthritis Patients Tapering DMARD Treatment Arthritis Rheumatol. 2015;67 10: -
Kocijan R, Englbrecht M, Haschka J, Simon D, Kleyer A, Finzel S, Kraus S, Resch H, Muschitz C, Engelke K, Sticherling M, Rech J, Schett G: Quantitative and Qualitative Changes of Bone in Psoriasis and Psoriatic Arthritis Patients. J Bone Miner Res. 2015;30(10): 1775-83
McInnes IB, Mease PJ, Kirkham B, Kavanaugh A, Ritchlin CT, Rahman P, van der Heijde D, Landewé R, Conaghan PG, Gottlieb AB, Richards H, Pricop L, Ligozio G, Patekar M, Mpofu S, FUTURE 2 Study Group , Bird P, Hall S, Nash P, Zochling J, de Vlam K, Langenaken C, Geusens P, Beaulieu A, Tremblay JL, McCarthy T, Papp K, Poulin Y, Cohen M, Galatikova D, Dokoupilova E, Dvorak Z, Mann H, Sieper J, Spieler W, Kurthen R, Braun J, Wollenhaupt J, Tony HP, Schuch F, Schulze-Koops H, Rech J, Leszczynski P, Adamski Z, Szepietowski J, Tlustochowicz W, Kaszuba A, Szymanska M, Stanislav M, Nesmeyanova O, Vezikova N, Ershova O, Izmozherova N, Zotkin E, Petrova M, Kastanayan A, Yakupova S, Agafina A, Asavatanabodee P, Suwannalai P, Kerrane J, Tahir H, Kirkham B, McInnes I, Edwards C, Chinoy H, Marzo-Ortega H, Kaul A, Sheeran T, Clunie G, Schechtman J, Gaylis N, Kaine J, Lawson J, El-Kadi H, Flint K, Kivitz A, Churchhill M, Sikes D, Lowenstein M, Halpert E, Abdulky M, Palmer W, Codding C, Legerton C, Singhal A, Sunkureddi P, Gough W, Forman S, Box J, Khan M, Barranco E: Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2015;386(9999): 1137-46
Mease PJ, McInnes IB, Kirkham B, Kavanaugh A, Rahman P, van der Heijde D, Landewé R, Nash P, Pricop L, Yuan J, Richards HB, Mpofu S, FUTURE 1 Study Group , Caeiro F, Soriano E, Baravalle M, Ceitlin R, Rillo O, Carrio J, Hall S, Nash P, Van den Bosch F, de Vlam K, Geusens P, Pinheiro M, Zerbini C, Keiserman M, Papp K, Lessard C, Tremblay JL, Rahman P, Mustafa M, Thorne J, Langevitz P, Reitblat T, Rosner I, Elkayam O, Frediani B, Foti R, Cantini F, Adami S, Navarra S, Perez E, Lanzon A, Baes R, Lucero A, Gulay-Carvajal C, Li-Yu J, Tan P, Javier J, Chirieac R, Ionescu RM, Rednic S, Nasonov E, Stanislav M, Raskina T, Ershova O, Izmozherova N, Lesnyak O, Zotkin E, Yoon KH, Lim A, Leung YY, Asavatanabodee P, Suwannalai P, Nanagara R, Louthrenoo W, Strapkova M, Tahir H, Mc Innes I, Sheeran T, Helliwell P, Kirkham B, Shimbova K, Stoilov R, Mihaylova M, Dokoupilova E, Vitek P, Galatikova D, Janecka I, Supronik J, Sieper J, Kurthen R, Dahmen G, Demary W, Nuesslein H, Degtyareva E, Maus O, Kekow J, Rubbert-Roth A, Rech J, Schuch F, Wassenberg S, Martz R, Spieler W, Braun J, Halpert E, Moreta E, Box J, Legerton C, Flint K, Starr J, Jajoo R, Caldron P, Tesser J, Frankel E, El-Kadi H, Petrone D, Reimold A, Singhal A, Sunkureddi P, Wellborne F, Budd J, Codding C, Kohen M, Kivitz A, Chindalore V, Mease P, Aelion J, Lee E, Valente R, Gottlieb A: Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis. N Engl J Med. 2015;373(14): 1329-39
Baeten D, Sieper J, Braun J, Baraliakos X, Dougados M, Emery P, Deodhar A, Porter B, Martin R, Andersson M, Mpofu S, Richards HB, MEASURE 1 Study Group , MEASURE 2 Study Group , Van den Bosch F, Nzeusseu A, de Vlam K, Geusens P, Oparanov B, Rashkov R, Batalov A, Goranov I, Kazmin I, McCarthy T, Inman R, Rahman P, Schaeverbeke T, N'Guyen M, Bertin P, Frediani B, Adami S, Foti R, Triolo G, Fusaro E, Franceschini F, Zazueta B, Maradiaga M, Avila H, Garza M, Baeten D, Bijlsma H, Berrocal A, Garro B, Gamboa R, Castaneda O, Becerra F, Stanislav M, Salnikova T, Maslyanskiy A, Ershova O, Izmozherova N, Lesniak O, Tseng JC, Wei CC, Ozdogan H, Kisacik B, Onen F, Tahir H, Ostor A, Barkham N, Kay L, Braun J, Dahmen G, Rubbert-Roth A, Wassenberg S, Oelzner P, Nuesslein H, Moericke R, Rech J, Sieper J, Deodhar A, Kivitz A, Aelion J, Kohen M, Knibbe W, LaSalle S, Zang S, Cohen S, Brooks M, Graninger W, Jorg R, Zamani O, Bessette L, Cohen M, McCarthy T, Beaulieu A, Pavelka K, Galatikova D, Dokoupilova E, Leirisalo-Repo M, Paimela L, Järvinen P, Sokka-Isler T, Rouhe E, keskussairaala S, Foti R, Pellerito R, Adami S, Baeten D, Bijlsma J, Trofimov V, Izmozherova N, Vezikova N, Zotkin E, Stanislav M, Ershova O, Mosesova N, Lee LN, Cheung P, Balsa A, Blanco R, Blanco FJ, Gonzalez C, Bannert B, Daniela B, Dudler J, Ciurea A, Tahir H, Marzo-Ortega H, Gaffney K, Mackay K, Codding C, Dorman W, Legerton C, Kivitz A, Khan M, Lee E, Caldron P, Wolfe J, Swarup A, Singhal A, Braun J, Sieper J, Tony HP: Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis. N Engl J Med. 2015;373(26): 2534-48
Regensburger A, Rech J, Englbrecht M, Finzel S, Kraus S, Hecht K, Kleyer A, Haschka J, Hueber AJ, Cavallaro A, Schett G, Faustini F: A comparative analysis of magnetic resonance imaging and high-resolution peripheral quantitative computed tomography of the hand for the detection of erosion repair in rheumatoid arthritis. Rheumatology (Oxford). 2015;54(9): 1573-81
Araujo EG, Bayat S, Petsch C, Englbrecht M, Faustini F, Kleyer A, Hueber AJ, Cavallaro A, Lell M, Dalbeth N, Manger B, Schett G, Rech J: Tophus resolution with pegloticase: a prospective dual-energy CT study. RMD Open. 2015;1(1): e000075
Kocijan R, Muschitz C, Rech J: Anti-TNFs in axial spondyloarthritis. Wien Med Wochenschr. 2015;165(1-2): 10-3
Kocijan R, Muschitz C, Rech J: Biological agents in psoriatic arthritis. Wien Med Wochenschr. 2015;165(1-2): 36-39
Kocijan R, Finzel S, Englbrecht M, Engelke K, Rech J, Schett G: Differences in bone structure between rheumatoid arthritis and psoriatic arthritis patients relative to autoantibody positivity. Ann Rheum Dis. 2014;73(11): 2022-8
Kleyer A, Finzel S, Rech J, Manger B, Krieter M, Faustini F, Araujo E, Hueber AJ, Harre U, Engelke K, Schett G: Bone loss before the clinical onset of rheumatoid arthritis in subjects with anticitrullinated protein antibodies. Ann Rheum Dis. 2014;73(5): 854-60
Herz B, Albrecht A, Englbrecht M, Welsch GH, Uder M, Renner N, Schlechtweg P, Paul D, Lauer L, Engelke K, Janka R, Rech J, Schett G, Finzel S: Osteitis and synovitis, but not bone erosion, is associated with proteoglycan loss and microstructure damage in the cartilage of patients with rheumatoid arthritis. Ann Rheum Dis. 2014;73(6): 1101-6
Ritchlin C, Rahman P, Kavanaugh A, McInnes IB, Puig L, Li S, Wang Y, Shen YK, Doyle MK, Mendelsohn AM, Gottlieb AB, PSUMMIT 2 Study Group , Alten R, Birbara C, Boh E, Braun J, Budd J, Chattapadhyay C, Chudzik D, Claudepierre P, Cooper R, Drescher E, Dutz J, Edwards C, Elewski B, El-Kadi H, Erlacher L, Flipo R, Fretzin SA, George E, Gladstein G, Griffin RM, Grisanti MW, Guenther L, Gulliver W, Hobbs K, Huang E, Ilivanova E, Jeka S, Khraishi M, Kokhan M, Korman N, Kunynetz R, Leonardi CL, Lessard C, Lindquist U, Martin A, Matheson RT, Murphy FT, Nasonov E, Palmer W, Papp K, Rech J, Rell-Bakalarska M, Rich P, Rosen C, Rudin A, Ruppert-Roth A, Scheinecker C, Seigel S, Shaikh S, Sheeran T, Shergy WJ, Siegel EL, Sierakowski S, Sofen H, Szanto S, Tahir H, Telegdy E, Toth D, Walker D, Wilson AG, Witt M, Wollenhaupt J, Zoschke D, Zubrzycka A: Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, m Ann Rheum Dis. 2014;73(6): 990-9
Kleyer A, Krieter M, Faustini F, Kammerer N, Rech J, Schett G: DETAILED ANALYSIS OF MRI LESIONS IN SUBJECTS WITH ACPA BUT NO CLINICAL SIGNS OF ARTHRITIS Ann Rheum Dis. 2014;73 2: 1126-1126
Schett G, Finzel S, Rech J, Sasso EH, Segurado OG: RESIDUAL INFLAMMATORY ACTIVITY ASSESSED BY A MULTI-BIOMARKER DISEASE ACTIVITY BLOOD TEST IS LINKED TO STRUCTURAL DAMAGE IN RA PATIENTS IN LOW DISEASE ACTIVITY/REMISSION AND NORMAL C-REACTIVE PROTEIN LEVEL Ann Rheum Dis. 2014;73 2: 270-270
Kleyer A, Hueber AJ, Rech J, Stemmler F, Kroenke G, Simon D, Schett G: INTRODUCTION OF 3D PRINTING INTO RHEUMATOLOGY-TRANSFERRING IMAGES FROM ARTHRITIC JOINTS INTO MODELS Ann Rheum Dis. 2014;73 2: 464-464
Alexander T, Sarfert R, Klotsche J, Rubbert-Roth A, Lorenz HM, Rech J, Hoyer B, Cheng Q, Waka A, Taddeo A, Kuhl AA, Schett G, Burmester GR, Radbruch A, Hiepe F, Voll RE: THE PROTEASOME INHIBITOR BORTEZOMIB AMELIORATES REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): A PROSPECTIVE MULTI-CENTRE OBSERVATIONAL STUDY Ann Rheum Dis. 2014;73 2: 530-530
Petsch C, Araujo E, Englbrecht M, Hueber A, Lell M, Schett G, Manger B, Rech J: GOUT AND RA: NOT SUCH A RARE COEXISTENCE AFTER ALL? Ann Rheum Dis. 2014;73 2: 636-637
Simon D, Faustini F, Englbrechtl M, Kleyer A, Kocijan R, Haschka J, Kraus S, Hueber AJ, Sticherling M, Schell G, Rech J: MAGNETIC RESONANCE IMAGING (MRI) OF HANDS OF PSORIASIS PATIENTS: HIGH INCIDENCE OF INFLAMMATION Ann Rheum Dis. 2014;73 2: 656-656
Haschka J, Simon D, Rech J, Hueber AJ, Schett G, Kleyer A: IN VIVO DETECTION OF CORTICAL MICRO CHANNELS IN METACARPOPHALANGEAL JOINTS WITH XTREME-CT - A NEW INSTRUMENT TO VISUALIZE COMMUNICATION BETWEEN THE BONE MARROW AND THE JOINT SPACE Ann Rheum Dis. 2014;73 2: 659-659
Renner N, Krönke G, Rech J, Uder M, Janka R, Lauer L, Paul D, Herz B, Schlechtweg P, Hennig FF, Schett G, Welsch G: Anti-citrullinated protein antibody positivity correlates with cartilage damage and proteoglycan levels in patients with rheumatoid arthritis in the hand joints. Arthritis Rheumatol. 2014;66(12): 3283-8
Haschka J, Rech J, Englbrecht M, Finzel S, Reiser M, Hueber AJ, Kleyer A, Tony HP, Fleck M, Manger K, Ochs W, Wendler J, Lorenz HM, Nusslein H, Alten R, Demary W, Schett G: Reducing Therapy in Rheumatoid Arthritis Patients in Ongoing Remission. Arthritis Rheumatol. 2014;66 10: S418-S418
Simon D, Faustini F, Englbrecht M, Kleyer A, Kocijan R, Haschka J, Kraus S, Hueber AJ, Sticherling M, Schett G, Rech J: Subclinical Inflammation in Psoriatic Patients with No History of Psoriatic Arthritis: An Assessment By Magnetic Resonance Imaging. Arthritis Rheumatol. 2014;66 10: S521-S521
Simon D, Faustini F, Kleyer A, Haschka J, Werner D, Hueber AJ, Sticherling M, Schett G, Rech J: In Vivo Visualization of Cortical Microchannels in Metacarpal Bones in Patients with Cutaneous Psoriasis By High Resolution Peripheral Computed tomography - Detecting Cortical Pathologies before the Clinical Onset of Psoriatic-Arthritis. Arthritis Rheumatol. 2014;66 10: S832-S833
Simon D, Faustini F, Englbrecht M, Kleyer A, Kocijan R, Haschka J, Finzel S, Kraus S, Hueber AJ, Sticherling M, Schett G, Rech J: Bone Microstructure in Patients with Cutaneous Psoriasis and No History of Psoriatic Arthritis Shows Bone Anabolic Changes at a Greater Extent Than in Healthy Controls. Arthritis Rheumatol. 2014;66 10: S931-S932
Rech J, Faustini F, Hueber AJ, Ochs W, Spieler W, Kellner H, Muller-Ladner U, Grunke M, Schneider M, Schett G: A PHASE 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy Study of Apremilast (CC-10004) in Subjects with Erosive Hand Osteoarthritis. Arthritis Rheumatol. 2014;66 10: S971-S972
Kocijan R, Finzel S, Englbrecht M, Engelke K, Rech J, Schett G: Decreased Quantity and Quality of the Periarticular and Nonperiarticular Bone in Patients With Rheumatoid Arthritis: A Cross-Sectional HR-pQCT Study. J Bone Miner Res. 2014;29(4): 1005-14
Kocijan R, Englbrecht M, Kleyer A, Haschka J, Simon D, Finzel S, Kraus S, Muschitz C, Resch H, Engelke K, Rech J, Schett G: Systemic and local bone loss in Psoriasis and Psoriatic Arthritis J Bone Miner Res. 2014;29 1: S293-S293
Lee EB, Fleischmann R, Hall S, Wilkinson B, Bradley JD, Gruben D, Koncz T, Krishnaswami S, Wallenstein GV, Zang C, Zwillich SH, van Vollenhoven RF, ORAL Start Investigators , Lue C, Schnitz WM, Baraf HS, Bolster MB, Kivitz AJ, Kimmel SC, Fudman EJ, Quaidoo EA, Churchill MA, Birbara CA, Longley S, Stohl W, Niemer MW, Payne DD, Kaine JL, Kafka SP, Fleischmann RM, Charles-Schoeman CM, Kavanaugh AF, Kremer JM, Ritter JS, Stack MT, Barron MC, Aelion JA, Griffin RM, Peng SL, Walsh BT, Silverfield JC, Ghirlanda MR, Tate GA, Citera G, Ximenes AC, Radominski SC, Keiserman MW, Zerbini CA, Calabresse RJ, Cabezas PC, Ponce L, Silva MO, Flores AM, Tobias ED, Velez-Sanchez PJ, Raad JJ, Escalante WJ, Alpizar R, Alvarez-Mata R, Diaz-Coto JF, Alvarez-Felix P, Ramos-Remus DC, Esquivel-Valerio JA, Rodriguez-Torres IM, Avila-Armengol HE, Jimenez MO, Romero FJ, Perich R, Salinas AR, Perez RL, Van den Bosch FE, Goranov I, Bichovska D, Stoilov RM, Kopcheva S, Yordanova NG, Oparanov B, Bradna P, Stejfova Z, Mosterova Z, Vencovsky J, Rosypalova M, Fojtik Z, Alten R, Wollenhaupt J, Nuesslein H, Wassenberg S, Rech J, Wagner S, Kurthen R, Schoo U, Szombati I, Kovacs A, Samson L, Nazon S, Peterfai E, Sulyok G, Cseuz R, Rell-Bakalarska M, Dudek A, Grabowicz-Wasko B, Glogowska-Szelag J, Polak P, Belica P, Ujvari I, Szolnokiova A, Lukac J, Meijide JG, Sarabia FN, Nebro AF, Gonzalez-Fernandez CM, Angulo EU, Albizuri JM, Sahlqvist AO, Svensson J, Theander E, Hall S, Nash PT, Rischmueller M, Faraawi R, Rodrigues JF, Cividino AA, McKendry RJ, Jones HN, Jaroszynska AM, Shaikh SR, Bensen WG, Chopra AK, Kadel JK, Veeravalli SC, Sharma R, Venkataiya MK, Pandya S, Wagh S, Lee EB, Yoo B, Park YB, Gun SC, Chow SK, The CL, Gow PJ, Singh GJ, Gilchrist NL, Doube A, Ching DW, Taylor WJ, Ramiterre EB, Tan PP, Eullaran R, Stetsiouk OU, Usova G, Ushakova EN, Esip V, Sarana AM, Maslyanskiy AL, Dorokhov AE, Eliseeva L, Raskina TA, Zonova EV, Izmozherova NV, Lesnyak OM, Tsai WC, Chen DY, Lan JL, Liu MF, Katchamart W, Asavatanabodee P, Kitumnuaypong T, Hrytsenko HM, Petrov AV, Povoroznyuk VV, Stanislavchuk MA, Svintsitskyy AS, Kolomiyets SM: Tofacitinib versus methotrexate in rheumatoid arthritis. N Engl J Med. 2014;370(25): 2377-86
Kleyer A, Finzel S, Rech J, Schett G: Characterization of bone changes in ACPA-positive individuals without signs of arthritis compared to ACPA-negative, healthy subjects with HR-pQCT measurements of MCP joints Z Rheumatol. 2014;73 1: 8-8
Rech J: Comparing the OMERACT Psoriatic Arthritis Magnetic Resonance Imaging Score (PsAMRIS) with PSA-like joint alterations detected by Mikro-CT in patients with psoriasis without clinical symptoms of psoriatic arthritis Z Rheumatol. 2014;73 1: 8-8
Finzel S, Rech J, Schmidt S, Engelke K, Englbrecht M, Schett G: Interleukin-6 receptor blockade induces limited repair of bone erosions in rheumatoid arthritis: a micro CT study. Ann Rheum Dis. 2013;72(3): 396-400
Finzel S, Kraus S, Schmidt S, Hueber A, Rech J, Engelke K, Englbrecht M, Schett G: Bone anabolic changes progress in psoriatic arthritis patients despite treatment with methotrexate or tumour necrosis factor inhibitors. Ann Rheum Dis. 2013;72(7): 1176-81
Albrecht A, Finzel S, Englbrecht M, Rech J, Hueber A, Schlechtweg P, Uder M, Schett G: The structural basis of MRI bone erosions: an assessment by microCT. Ann Rheum Dis. 2013;72(8): 1351-7
Regensburger A, Koch P, Kraus S, Hecht C, Englbrecht M, Rech J, Schett G, Faustini F, Finzel S: A COMPARATIVE ANALYSIS OF EROSION REPAIR IN RHEUMATOID ARTHRITIS (RA) PATIENTS BY MAGNETIC RESONANCE IMAGING (MRI)AND HR-PQCT Ann Rheum Dis. 2013;72 3: 534-534
Hecht CF, Englbrecht M, Schmidt S, Rech J, Engelke K, Araujo E, Schett G, Finzel S: ANTI-CITRULLINATED PROTEIN ANTIBODIES BUT NOT RHEUMATOID FACTOR ARE ASSOCIATED WITH LARGER BONE EROSIONS IN RA PATIENTS-A CROSS-SECTIONAL HR-PQCT STUDY Ann Rheum Dis. 2013;72 3: 537-538
Kocijan R, Finzel S, Englbrecht M, Kleyer A, Rech J, Schett G: SEROPOSITIVE RHEUMATOID ARTHRITIS HAS A DISTINCTIVE BONE PHENOTYPE AT THE ULTRA-DISTAL RADIUS COMPARED TO SERONEGATIVE RHEUMATOID ARTHRITIS AND PSORIATIC ARTHRITIS Ann Rheum Dis. 2013;72 3: 756-756
Aschenberg S, Finzel S, Schmidt S, Kraus S, Engelke K, Englbrecht M, Rech J, Schett G: Catabolic and anabolic periarticular bone changes in patients with rheumatoid arthritis: a computed tomography study on the role of age, disease duration and bone markers. Arthritis Res Ther. 2013;15(3): R62
Rech J, Hess A, Finzel S, Kreitz S, Sergeeva M, Englbrecht M, Doerfler A, Saake M, Schett G: Association of brain functional magnetic resonance activity with response to tumor necrosis factor inhibition in rheumatoid arthritis. Arthritis Rheum. 2013;65(2): 325-33
Huchzermeyer C, Mardin C, Holbach L, Zwerina J, Schett G, Rech J: Successful remission induction with a combination therapy of rituximab, cyclophosphamide, and steroids in a patient with refractory optic neuritis in Wegener's granulomatosis. Clin Rheumatol. 2013;32 Suppl 1: 97-101
Sarter K, Janko C, André S, Muñoz LE, Schorn C, Winkler S, Rech J, Kaltner H, Lorenz HM, Schiller M, Andreoli L, Manfredi AA, Isenberg DA, Schett G, Herrmann M, Gabius HJ: Autoantibodies against galectins are associated with antiphospholipid syndrome in patients with systemic lupus erythematosus. Glycobiology. 2013;23(1): 12-22
Kleyer A, Finzel S, Rech J, Schett G: Bone Changes (Bone Density/Cortical Density/Bone Structure) in CCP-AB positive Patients without Clinical Arthritis compared with healthy Subjects using the HR-pQCT Method Internist. 2013;54 1: 54-54
Witsch J, Bohner G, Rech J, Trendelenburg G: Perivascular white matter lesion pattern in a patient with steroid-responsive encephalopathy. J Neurol. 2013;260(3): 923-4
Englbrecht M, Kruckow M, Araujo E, Rech J, Schett G: The interaction of physical function and emotional well-being in rheumatoid arthritis--what is the impact on disease activity and coping? Semin Arthritis Rheum. 2013;42(5): 482-91
Finzel S, Rech J, Kleyer A: [High-resolution peripheral quantitative CT (HR-pQCT). New insights into arthritis]. Z Rheumatol. 2013;72(2): 129-36
Hueber A, Rech J: A new measure for tight control?! - Detection of early central changes in rheumatoid arthritis patients by functional MRI and its correlation to the neurohormonal axis Z Rheumatol. 2013;72 1: 7-7
Vaglio A, Strehl JD, Manger B, Maritati F, Alberici F, Beyer C, Rech J, Sinico RA, Bonatti F, Battistelli L, Distler JH, Schett G, Zwerina J: IgG4 immune response in Churg-Strauss syndrome. Ann Rheum Dis. 2012;71(3): 390-3
Manger B, Lell M, Wacker J, Schett G, Rech J: Detection of periarticular urate deposits with dual energy CT in patients with acute gouty arthritis. Ann Rheum Dis. 2012;71(3): 470-2
Amann K, Bogdan C, Harrer T, Rech J: Renal leishmaniasis as unusual cause of nephrotic syndrome in an HIV patient. J Am Soc Nephrol. 2012;23(4): 586-90
Rech J, Manger B, Lang B, Schett G, Wilhelm M, Birkmann J: Adult-onset Still's disease and chronic recurrent multifocal osteomyelitis: a hitherto undescribed manifestation of autoinflammation. Rheumatol Int. 2012;32(6): 1827-9
Lang VR, Englbrecht M, Rech J, Nusslein H, Manger K, Schuch F, Tony HP, Fleck M, Manger B, Schett G, Zwerina J: Risk of infections in rheumatoid arthritis patients treated with tocilizumab Rheumatology. 2012;51(5): 852-857
Lang VR, Englbrecht M, Rech J, Nüsslein H, Manger K, Schuch F, Tony HP, Fleck M, Manger B, Schett G, Zwerina J: Risk of infections in rheumatoid arthritis patients treated with tocilizumab. Rheumatology (Oxford). 2012;51(5): 852-7
Dandorfer SW, Rech J, Manger B, Schett G, Englbrecht M: Differences in the patient's and the physician's perspective of disease in psoriatic arthritis. Semin Arthritis Rheum. 2012;42(1): 32-41
Rech J, Ronneberger M, Englbrecht M, Finzel S, Katzenbeisser J, Manger K, Manger B, Schett G: Successful treatment of adult-onset Still's disease refractory to TNF and IL-1 blockade by IL-6 receptor blockade. Ann Rheum Dis. 2011;70(2): 390-2

PD Dr. J. Rech

Medicine 3

Publications: Priv.-Doz. Dr. med. J. Rech